Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity
Abstract Prognostic markers are needed to understand the disease course and severity in patients with Covid-19. There is evidence that Covid-19 causes gastrointestinal symptoms and abnormalities in liver enzymes. We aimed to determine if hepatobiliary laboratory data could predict disease severity i...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c16739b7d0d04709b1fa1ea2a1c8ef54 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c16739b7d0d04709b1fa1ea2a1c8ef54 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c16739b7d0d04709b1fa1ea2a1c8ef542021-12-02T17:15:36ZElevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity10.1038/s41598-021-89340-y2045-2322https://doaj.org/article/c16739b7d0d04709b1fa1ea2a1c8ef542021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89340-yhttps://doaj.org/toc/2045-2322Abstract Prognostic markers are needed to understand the disease course and severity in patients with Covid-19. There is evidence that Covid-19 causes gastrointestinal symptoms and abnormalities in liver enzymes. We aimed to determine if hepatobiliary laboratory data could predict disease severity in patients with Covid-19. In this retrospective, single institution, cohort study that analyzed patients admitted to a community academic hospital with the diagnosis of Covid-19, we found that elevations of Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT) and Alkaline Phosphatase (AP) at any time during hospital admission increased the odds of ICU admission by 5.12 (95% CI: 1.55–16.89; p = 0.007), 4.71 (95% CI: 1.51–14.69; p = 0.01) and 4.12 (95% CI: 1.21–14.06, p = 0.02), respectively. Hypoalbuminemia found at the time of admission to the hospital was associated with increased mortality (p = 0.02), hypotension (p = 0.03), and need for vasopressors (p = 0.02), intubation (p = 0.01) and hemodialysis (p = 0.002). Additionally, there was evidence of liver injury: AST was significantly elevated above baseline in patients admitted to the ICU (54.2 ± 15.70 U/L) relative to those who were not (9.2 ± 4.89 U/L; p = 0.01). Taken together, this study found that hypoalbuminemia and abnormalities in hepatobiliary laboratory data may be prognostic factors for disease severity in patients admitted to the hospital with Covid-19.Jason WagnerVictor Garcia-RodriguezAbraham YuBarbara DutraScott LarsonBrooks CashAndrew DuPontAhmad FarooqNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-5 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Jason Wagner Victor Garcia-Rodriguez Abraham Yu Barbara Dutra Scott Larson Brooks Cash Andrew DuPont Ahmad Farooq Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity |
description |
Abstract Prognostic markers are needed to understand the disease course and severity in patients with Covid-19. There is evidence that Covid-19 causes gastrointestinal symptoms and abnormalities in liver enzymes. We aimed to determine if hepatobiliary laboratory data could predict disease severity in patients with Covid-19. In this retrospective, single institution, cohort study that analyzed patients admitted to a community academic hospital with the diagnosis of Covid-19, we found that elevations of Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT) and Alkaline Phosphatase (AP) at any time during hospital admission increased the odds of ICU admission by 5.12 (95% CI: 1.55–16.89; p = 0.007), 4.71 (95% CI: 1.51–14.69; p = 0.01) and 4.12 (95% CI: 1.21–14.06, p = 0.02), respectively. Hypoalbuminemia found at the time of admission to the hospital was associated with increased mortality (p = 0.02), hypotension (p = 0.03), and need for vasopressors (p = 0.02), intubation (p = 0.01) and hemodialysis (p = 0.002). Additionally, there was evidence of liver injury: AST was significantly elevated above baseline in patients admitted to the ICU (54.2 ± 15.70 U/L) relative to those who were not (9.2 ± 4.89 U/L; p = 0.01). Taken together, this study found that hypoalbuminemia and abnormalities in hepatobiliary laboratory data may be prognostic factors for disease severity in patients admitted to the hospital with Covid-19. |
format |
article |
author |
Jason Wagner Victor Garcia-Rodriguez Abraham Yu Barbara Dutra Scott Larson Brooks Cash Andrew DuPont Ahmad Farooq |
author_facet |
Jason Wagner Victor Garcia-Rodriguez Abraham Yu Barbara Dutra Scott Larson Brooks Cash Andrew DuPont Ahmad Farooq |
author_sort |
Jason Wagner |
title |
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity |
title_short |
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity |
title_full |
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity |
title_fullStr |
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity |
title_full_unstemmed |
Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity |
title_sort |
elevated transaminases and hypoalbuminemia in covid-19 are prognostic factors for disease severity |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/c16739b7d0d04709b1fa1ea2a1c8ef54 |
work_keys_str_mv |
AT jasonwagner elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT victorgarciarodriguez elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT abrahamyu elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT barbaradutra elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT scottlarson elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT brookscash elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT andrewdupont elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity AT ahmadfarooq elevatedtransaminasesandhypoalbuminemiaincovid19areprognosticfactorsfordiseaseseverity |
_version_ |
1718381283914022912 |